Vericel (VCEL)
Markets patient-specific cell therapies for knee-cartilage repair and severe burns, plus enzymatic burn debridement.
$40.22
After hours0.00 (0.00%)
At close$40.22(+1.69%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 107.70% | 55.15M shares | |
|---|---|---|---|
| 325 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 1.22% | 622.9K shares | |
| 14 holders · as of Aug 14, 2026 | |||
| Strategic holders | 6.26% | 3.20M shares | |
| 1 holder · as of Feb 14, 2022 | |||
| Adds to | 115.18% | ||
51.21M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 115.18%; nothing is left for Other.
13F, as of Jun 30, 2026
325 holders · 55.15M shares · 67 new positions · 188 increased · 100 reduced · 26 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 8.09M | 15.80% | +326.9K | Aug 7, 2026 |
| State Street Corp | 3.29M | 6.43% | +141.8K | Aug 7, 2026 |
| Congress Asset Management Co /MA | 2.92M | 5.70% | +1.41M | Jul 7, 2026 |
| Vanguard Capital Management LLC | 2.26M | 4.41% | +25.0K | Aug 13, 2026 |
| Conestoga Capital Advisors, LLC | 2.08M | 4.07% | −379.5K | Jul 24, 2026 |
| William Blair Investment Management, LLC | 1.99M | 3.89% | +160.1K | Aug 12, 2026 |
| BNP Paribas Asset Management Holding S.A. | 1.64M | 3.20% | −83.6K | Aug 13, 2026 |
| GW&K Investment Management, LLC | 1.55M | 3.03% | −66.4K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.10% | 7.57M | 13G | Apr 30, 2025 |
| State Street Corporation | 5.60% | 2.81M | 13G | Nov 10, 2025 |
| Vanguard Capital Management | 5.11% | 2.60M | 13G | Apr 30, 2026 |
| Soleus Capital Master Fund, L.P. | 5.00% | 2.55M | 13G | Apr 1, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 12, 2026 | Kevin F. Mclaughlindirector | Sale | 7,000 | $44.53 | 18,300 |
| Aug 3, 2026 | Michael Halpinofficer: Chief Operating Officer | Sale | 10,000 | $46.84 | 16,394 |
| Jul 30, 2026 | Jonathan Siegalofficer: Principal Accounting Officer | Sale | 500 | $48.90 | 1,078 |
| Jun 26, 2026 | Sean C. Flynnofficer: Chief Legal Officer | Sale | 15,000 | $45.64 | 1,647 |
| Jun 26, 2026 | Jonathan Mark Hopperofficer: Chief Medical Officer | Sale | 5,000 | $45.00 | 75,753 |
| Jun 26, 2026 | Joseph Anthony Jr Maraofficer: Chief Financial Officer | Sale | 5,000 | $44.75 | 16,009 |
| Jun 26, 2026 | Jonathan Siegalofficer: Principal Accounting Officer | Sale | 2,500 | $44.90 | 886 |
| Jun 18, 2026 | Sean C. Flynnofficer: Chief Legal Officer | Sale | 15,000 | $40.21 | 1,647 |
| Jun 18, 2026 | Michael Halpinofficer: Chief Operating Officer | Sale | 10,000 | $40.24 | 16,248 |
| Jun 2, 2026 | Jonathan Mark Hopperofficer: Chief Medical Officer | Sale | 4,375 | $35.00 | 75,753 |
House and Senate disclosures
Not reported.